Finally, observations using trypsin made by Watanabe et al., [39] showed that PT76 is outside the trypsin resistant core of the aggregate, which would mean that this epitope is exposed in Tau aggregates obtained from AD patients postmortem material. This evidence concerns the gene MAPT and Alzheimer disease.